Luteinising Hormone
| Luteinising Hormone | |
| LH, LF | |
| Serum (brown), Plasma (orange) | |
| 24hrs | |
| LH concentration is used in the assessment of dysfunctions within the hypothalamus-pituitary-gonads system. The determination of LH in conjunction with FSH is utilised for the following indications: congenital diseases with chromosome aberrations (e.g. Turners syndrome), polycystic ovaries (PCO), clarifying the causes of amenorrhea, menopausal syndrome, and suspected Leydig cell insufficiency. | |
| No known common methodological interferences. | |
|
Male (adult): 1.7-8.6 U/L Female (adult): Follicular phase: 2.4 - 12.6 U/L Ovulation phase: 14.0 - 95.6 U/L Luteal phase: 1.0 - 11.4 U/L Postmenopausal: 7.7 - 58.5 U/L
Reference ranges based on 5th - 95th percentile interval
|
|
| Analytical Error [1] | 3.9% |
| Reference Change Value [1] | 67.4% |
